Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
19.56
+1.18 (6.42%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Viridian Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -386.97 | -342.6 | -269.95 | -237.73 | -129.87 | -79.41 |
Depreciation & Amortization | 0.47 | 0.46 | 0.54 | 0.52 | 0.26 | 0.12 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.08 |
Loss (Gain) From Sale of Investments | -6.19 | -6.76 | -15.66 | -11.49 | -0.21 | 0.96 |
Stock-Based Compensation | 53.61 | 44.3 | 42.15 | 67.17 | 19.77 | 14.47 |
Other Operating Activities | 7.95 | 5.17 | 1 | 6.79 | 0.26 | 7.49 |
Change in Accounts Receivable | - | - | - | - | 0.35 | -0.45 |
Change in Accounts Payable | -0.41 | 6.56 | -0.07 | -12.04 | 11.52 | 1.66 |
Change in Unearned Revenue | - | - | - | - | -0.29 | 0.64 |
Change in Other Net Operating Assets | -1.8 | 16.47 | 9.67 | 2.62 | 4.38 | -0.12 |
Operating Cash Flow | -333.34 | -276.39 | -232.32 | -184.17 | -93.84 | -54.58 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.7 | -0.5 | -0.51 | -0.9 | -0.8 | -0.34 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.08 |
Investment in Securities | -365.54 | -37.07 | -228.14 | -93.35 | -114.33 | -74.03 |
Investing Cash Flow | -367.24 | -37.56 | -228.65 | -94.25 | -115.13 | -74.29 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 28.88 | - | 15 | 5 | - |
Total Debt Issued | 278.88 | 28.88 | - | 15 | 5 | - |
Net Debt Issued (Repaid) | 224.18 | 28.88 | - | 15 | 5 | - |
Issuance of Common Stock | 508.76 | 366.99 | 459.68 | 146.79 | 295.75 | 116.59 |
Other Financing Activities | 15.31 | 30.88 | -26.94 | -12.32 | -22.51 | -8.28 |
Financing Cash Flow | 748.24 | 426.74 | 457.74 | 225.67 | 322.24 | 125.28 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 47.66 | 112.79 | -3.23 | -52.75 | 113.28 | -3.6 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -335.04 | -276.89 | -232.83 | -185.07 | -94.64 | -54.92 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -471.04% | -390.81% | -77096.03% | -58938.85% | -5340.58% | -1853.49% |
Free Cash Flow Per Share | -3.47 | -3.27 | -3.43 | -4.13 | -2.95 | -4.61 |
Levered Free Cash Flow | -275.5 | -162.07 | -136.29 | -102.5 | -48.83 | -33.91 |
Unlevered Free Cash Flow | -265.74 | -158.98 | -134.92 | -101.66 | -48.52 | -33.91 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 3.47 | 2.15 | 1.82 | 0.89 | 0.29 | - |
Change in Working Capital | -2.2 | 23.03 | 9.6 | -9.43 | 15.96 | 1.72 |